Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
ClearPoint Neuro Price Target Raised to $15.00/Share From $11.00 by Lake Street
Lake Street Maintains Buy on ClearPoint Neuro, Raises Price Target to $15
ClearPoint Neuro Analyst Ratings
Express News | ClearPoint Neuro Announces Full Early Repayment Of $10M Convertible Note To PTC Therapeutics Ahead Of January 2025 Maturity
ClearPoint Neuro Announces Early Repayment of $10 Million Note
Express News | Clearpoint Neuro Announces Early Repayment of $10 Million Note
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Earnings Call: ClearPoint Neuro Sees Record Revenue of $7.9 Million
B. Riley Adjusts Price Target on ClearPoint Neuro to $10.50 From $10, Maintains Buy Rating
Express News | Clearpoint Neuro Inc : Stifel Raises Target Price to $10 From $9
ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript
Express News | ClearPoint Sees FY24 Revenue $30M-$33M Vs $30.52M Estimate
ClearPoint Neuro | 10-Q: Q2 2024 Earnings Report
Express News | ClearPoint Neuro Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate
ClearPoint Neuro GAAP EPS of -$0.16 Beats by $0.02, Revenue of $7.9M Beats by $0.57M
Express News | Clearpoint Neuro Reports Second Quarter 2024 Results
Express News | Clearpoint Neuro Outlook FY Revenue USD 30-33 Million
No Data
No Data